Dr. Alex Spira, MD, PhD
Claim this profileNEXT Oncology
Expert in Solid Tumors
Studies Non-Small Cell Lung Cancer
21 reported clinical trials
32 drugs studied
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
2Non-Small Cell Lung Cancer
Stage IV
EGFR positive
Stage III
Affiliated Hospitals
Clinical Trials Alex Spira, MD, PhD is currently running
Zipalertinib
for Non-Small Cell Lung Cancer
This trial is testing CLN-081, a new drug, in patients with a specific type of lung cancer that has a genetic mutation. The drug aims to block a protein that helps cancer cells grow, to see if it can slow down or stop the cancer.
Recruiting1 award Phase 1 & 23 criteria
IMM-1-104
for Solid Cancers
This trial is testing a new drug called IMM-1-104 to see if it can help treat advanced cancers with specific genetic changes. The drug works by blocking signals that make cancer cells grow.
Recruiting1 award Phase 1 & 2
More about Alex Spira, MD, PhD
Clinical Trial Related4 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Alex Spira, MD, PhD has experience with
- Nab-paclitaxel
- Pembrolizumab
- H002
- Upifitamab Rilsodotin
- ARTS-021
- CUSP06
Breakdown of trials Alex Spira, MD, PhD has run
Non-Small Cell Lung Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alex Spira, MD, PhD specialize in?
Alex Spira, MD, PhD focuses on Solid Tumors and Non-Small Cell Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Alex Spira, MD, PhD currently recruiting for clinical trials?
Yes, Alex Spira, MD, PhD is currently recruiting for 15 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Alex Spira, MD, PhD has studied deeply?
Yes, Alex Spira, MD, PhD has studied treatments such as Nab-paclitaxel, Pembrolizumab, H002.
What is the best way to schedule an appointment with Alex Spira, MD, PhD?
Apply for one of the trials that Alex Spira, MD, PhD is conducting.
What is the office address of Alex Spira, MD, PhD?
The office of Alex Spira, MD, PhD is located at: NEXT Oncology, Fairfax, Virginia 22031 United States. This is the address for their practice at the NEXT Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.